United Therapeutics Corporation (UTHR)
NASDAQ: UTHR · Real-Time Price · USD
381.36
+4.56 (1.21%)
Nov 5, 2024, 2:16 PM EST - Market open
United Therapeutics Revenue
United Therapeutics had revenue of $748.90M in the quarter ending September 30, 2024, with 22.89% growth. This brings the company's revenue in the last twelve months to $2.76B, up 25.04% year-over-year. In the year 2023, United Therapeutics had annual revenue of $2.33B with 20.20% growth.
Revenue (ttm)
$2.76B
Revenue Growth
+25.04%
P/S Ratio
6.25
Revenue / Employee
$2,359,760
Employees
1,168
Market Cap
17.07B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 2.33B | 391.20M | 20.20% |
Dec 31, 2022 | 1.94B | 250.80M | 14.88% |
Dec 31, 2021 | 1.69B | 202.20M | 13.63% |
Dec 31, 2020 | 1.48B | 34.50M | 2.38% |
Dec 31, 2019 | 1.45B | -179.00M | -11.00% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Molina Healthcare | 37.54B |
Baxter International | 15.00B |
Labcorp Holdings | 12.71B |
Quest Diagnostics | 9.54B |
ICON Public Limited Company | 8.31B |
Avantor | 6.82B |
Align Technology | 3.96B |
Revvity | 2.71B |
UTHR News
- 6 days ago - United Therapeutics Corporation (UTHR) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 6 days ago - United Therapeutics Corporation Reports Third Quarter 2024 Financial Results - Business Wire
- 13 days ago - United Therapeutics Corporation Announces the 500th Lung Transplant Utilizing its Centralized Ex Vivo Lung Perfusion Service - Business Wire
- 13 days ago - United Therapeutics Corporation to Report Third Quarter 2024 Financial Results Before the Market Opens on Wednesday, October 30, 2024 - Business Wire
- 6 weeks ago - United Therapeutics to Feature Clinical Data Across its Commercial and Development Portfolio at the CHEST 2024 Annual Meeting - Business Wire
- 2 months ago - United Therapeutics Publishes its 2024 Corporate Responsibility and Public Benefit Report Highlighting its Progress Toward a Future Where No Patient Gets Left Behind—Ever - Business Wire
- 2 months ago - United Therapeutics Shares Thrive - FXEmpire
- 2 months ago - United Therapeutics Corporation to Present at Upcoming Investor Conferences - Business Wire